US Non-Emergency Medical Transportation Market Growth Opportunities and Forecast by 2031

US Non-Emergency Medical Transportation Market Size and Forecast (2021 - 2031), Country Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Private Pay Patient Transportation, Insurance Backed Patient Transportation, Courier Services, and Others), Facility (Intra-Facility and Inter-Facility), Application (Dialysis, Routine Doctor Visits, Mental Health Related Appointments, Rehabilitation, and Others), End User (Hospitals and Clinics, Nursing Homes, Homecare Settings, MCO and State Agencies, Healthcare Payers, and Others), and Country

  • Status : Published
  • Report Code : TIPRE00029536
  • Category : Life Sciences
  • No. of Pages : 125
  • Available Report Formats : pdf-format excel-format

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Service Type, and Application, and End user

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Midwest, Northeast, South Korea, West

Frequently Asked Questions


Which service type is expected to dominate the market in the forecast period in US non-emergency medical transportation market?

The market segmentation by service type is led by private pay patient transportation segment that is growing significantly due to custom NEMT rate of reimbursements with higher margins compared to other, low-cost, and flexibility pay and less complicated billing process compared to Medicare and Medicaid services.

What will be the CAGR of US non-emergency medical transportation market?

The market is estimated to grow with a CAGR of 9.3% from 2023 to 2031.

What are the driving factors for the US non-emergency medical transportation market?

Key factors that are driving growth of the market are increasing demand for non-emergency medical transportation and aging population and increasing incidence of chronic conditions fuel the growth of the market.

What is non-emergency medical transportation?

Non-Emergency Medical Transportation (NEMT) covers transportation services offered to the patients who are not in an emergency or in need assistance getting to and from medical appointments avoiding travel which are costly. These services are most widely used by the eligible Medicaid and Medicare members.

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country level data:

4. US Non-Emergency Medical Transportation Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Medicaid MCO Health Plans and Advantages

4.4 Medicare MCO Health Plans and Advantages

5. US Non-Emergency Medical Transportation Market – Key Market Dynamics

5.1 US Non-Emergency Medical Transportation Market – Key Market Dynamics

5.2 Market Drivers

5.2.1 Increasing Demand for Non-Emergency Medical Transportation

5.2.2 Aging Population and Increasing Incidence of Chronic Conditions

5.3 Market Restraints

5.3.1 Lack of Efficient Oversight Systems and Fraud by Non-Emergency Medical Transportation Companies

5.4 Market Opportunities

5.4.1 Strategic Initiatives by NEMT and Transportation Network Companies

5.5 Future Trends

5.5.1 Expanding Role of Technology in NEMT

5.6 Impact of Drivers and Restraints:

6. US Non-Emergency Medical Transportation Market Analysis

6.1 US Non-Emergency Medical Transportation Market Revenue (US$ Million), 2021–2031

6.2 US Non-Emergency Medical Transportation Market Forecast and Analysis

7. US Non-Emergency Medical Transportation Market Analysis – by Service Type

7.1 Private Pay Patient Transportation

7.1.1 Overview

7.1.2 Private Pay Patient Transportation: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Insurance Backed Patient Transportation

7.2.1 Overview

7.2.2 Insurance Backed Patient Transportation: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Courier Services

7.3.1 Overview

7.3.2 Courier Services: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Others

7.4.1 Overview

7.4.2 Others: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

8. US Non-Emergency Medical Transportation Market Analysis – by Facility

8.1 Intra-Facility

8.1.1 Overview

8.1.2 Intra-Facility: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

8.2 Inter-Facility

8.2.1 Overview

8.2.2 Inter-Facility: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

9. US Non-Emergency Medical Transportation Market Analysis – by Application

9.1 Dialysis

9.1.1 Overview

9.1.2 Dialysis: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

9.2 Routine Doctor Visits

9.2.1 Overview

9.2.2 Routine Doctor Visits: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

9.3 Mental Health Related Appointments

9.3.1 Overview

9.3.2 Mental Health Related Appointments: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

9.4 Rehabilitation

9.4.1 Overview

9.4.2 Rehabilitation: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

10. US Non-Emergency Medical Transportation Market Analysis – by End User

10.1 Hospitals and Clinics

10.1.1 Overview

10.1.2 Hospitals and Clinics: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

10.2 Nursing Homes

10.2.1 Overview

10.2.2 Nursing Homes: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

10.3 Homecare Settings

10.3.1 Overview

10.3.2 Homecare Settings: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

10.4 MCO and State Agencies

10.4.1 Overview

10.4.2 MCO and State Agencies: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

10.5 Healthcare Payers

10.5.1 Overview

10.5.2 Healthcare Payers: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

10.6 Others

10.6.1 Overview

10.6.2 Others: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

11. US Non-Emergency Medical Transportation Market – Country Analysis

11.1 US

11.1.1 US Non-Emergency Medical Transportation Market Breakdown by Countries

11.1.2 US Non-Emergency Medical Transportation Market Revenue and Forecast and Analysis – by Country

11.1.2.1 US Non-Emergency Medical Transportation Market Revenue and Forecast and Analysis – by Country

11.1.2.2 Northeast: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

11.1.2.2.1 Northeast: US Non-Emergency Medical Transportation Market Breakdown by Service Type

11.1.2.2.2 Northeast: US Non-Emergency Medical Transportation Market Breakdown by Facility

11.1.2.2.3 Northeast: US Non-Emergency Medical Transportation Market Breakdown by Application

11.1.2.2.4 Northeast: US Non-Emergency Medical Transportation Market Breakdown by End User

11.1.2.3 Midwest: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

11.1.2.3.1 Midwest: US Non-Emergency Medical Transportation Market Breakdown by Service Type

11.1.2.3.2 Midwest: US Non-Emergency Medical Transportation Market Breakdown by Facility

11.1.2.3.3 Midwest: US Non-Emergency Medical Transportation Market Breakdown by Application

11.1.2.3.4 Midwest: US Non-Emergency Medical Transportation Market Breakdown by End User

11.1.2.4 South: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

11.1.2.4.1 South: US Non-Emergency Medical Transportation Market Breakdown by Service Type

11.1.2.4.2 South: US Non-Emergency Medical Transportation Market Breakdown by Facility

11.1.2.4.3 South: US Non-Emergency Medical Transportation Market Breakdown by Application

11.1.2.4.4 South: US Non-Emergency Medical Transportation Market Breakdown by End User

11.1.2.5 West: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

11.1.2.5.1 West: US Non-Emergency Medical Transportation Market Breakdown by Service Type

11.1.2.5.2 West: US Non-Emergency Medical Transportation Market Breakdown by Facility

11.1.2.5.3 West: US Non-Emergency Medical Transportation Market Breakdown by Application

11.1.2.5.4 West: US Non-Emergency Medical Transportation Market Breakdown by End User

12. US Non-Emergency Medical Transportation Market – Industry Landscape

12.1 Overview

12.2 Growth Strategies in the US Non-Emergency Medical Transportation Market

12.3 Organic Growth Strategies

12.3.1 Overview

12.4 Inorganic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 MTM, Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 AMR

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Xpress Transportation

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 CJ Medical Transportation

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 VERIDA

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 ModivCare

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Crothall Healthcare

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Elite Medical Transport

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Acadian Ambulance Service

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Transdev

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

13.11 Ride Health

13.11.1 Key Facts

13.11.2 Business Description

13.11.3 Products and Services

13.11.4 Financial Overview

13.11.5 SWOT Analysis

13.11.6 Key Developments

13.12 Roundtrip

13.12.1 Key Facts

13.12.2 Business Description

13.12.3 Products and Services

13.12.4 Financial Overview

13.12.5 SWOT Analysis

13.12.6 Key Developments

13.13 Medical Answering Services, LLC

13.13.1 Key Facts

13.13.2 Business Description

13.13.3 Products and Services

13.13.4 Financial Overview

13.13.5 SWOT Analysis

13.13.6 Key Developments

13.14 One Call

13.14.1 Key Facts

13.14.2 Business Description

13.14.3 Products and Services

13.14.4 Financial Overview

13.14.5 SWOT Analysis

13.14.6 Key Developments

13.15 Stellar Transport

13.15.1 Key Facts

13.15.2 Business Description

13.15.3 Products and Services

13.15.4 Financial Overview

13.15.5 SWOT Analysis

13.15.6 Key Developments

13.16 Abba Medical Transportation, LLC

13.16.1 Key Facts

13.16.2 Business Description

13.16.3 Products and Services

13.16.4 Financial Overview

13.16.5 SWOT Analysis

13.16.6 Key Developments

13.17 Able Medical Transportation, Inc.

13.17.1 Key Facts

13.17.2 Business Description

13.17.3 Products and Services

13.17.4 Financial Overview

13.17.5 SWOT Analysis

13.17.6 Key Developments

13.18 Life Ride

13.18.1 Key Facts

13.18.2 Business Description

13.18.3 Products and Services

13.18.4 Financial Overview

13.18.5 SWOT Analysis

13.18.6 Key Developments

13.19 Mobility Transportation Services, Inc.

13.19.1 Key Facts

13.19.2 Business Description

13.19.3 Products and Services

13.19.4 Financial Overview

13.19.5 SWOT Analysis

13.19.6 Key Developments

13.20 ABC Non-Emergency Medical Transportation, LLC

13.20.1 Key Facts

13.20.2 Business Description

13.20.3 Products and Services

13.20.4 Financial Overview

13.20.5 SWOT Analysis

13.20.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

List of Tables

Table 1. US Non-Emergency Medical Transportation Market Segmentation

Table 2. US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Table 3. US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by Service Type

Table 4. US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by Facility

Table 5. US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by Application

Table 6. US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 7. US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by Country

Table 8. Northeast: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by Service Type

Table 9. Northeast: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by Facility

Table 10. Northeast: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by Application

Table 11. Northeast: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 12. Midwest: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by Service Type

Table 13. Midwest: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by Facility

Table 14. Midwest: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by Application

Table 15. Midwest: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 16. South: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by Service Type

Table 17. South: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by Facility

Table 18. South: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by Application

Table 19. South: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 20. West: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by Service Type

Table 21. West: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by Facility

Table 22. West: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by Application

Table 23. West: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 24. Recent Organic Growth Strategies in the US Non-Emergency Medical Transportation Market

Table 25. Recent Inorganic Growth Strategies in the US Non-Emergency Medical Transportation Market

Table 26. Glossary of Terms, US Non-Emergency Medical Transportation Market

List of Figures

Figure 1. US Non-Emergency Medical Transportation Market Segmentation, by Country

Figure 2. PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. US Non-Emergency Medical Transportation Market Revenue (US$ Million), 2021–2031

Figure 5. US Non-Emergency Medical Transportation Market Share (%) – by Service Type, 2023 and 2031

Figure 6. Private Pay Patient Transportation: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7. Insurance Backed Patient Transportation: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8. Courier Services: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 9. Others: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10. US Non-Emergency Medical Transportation Market Share (%) – by Facility, 2023 and 2031

Figure 11. Intra-Facility: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12. Inter-Facility: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 13. US Non-Emergency Medical Transportation Market Share (%) – by Application, 2023 and 2031

Figure 14. Dialysis: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15. Routine Doctor Visits: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 16. Mental Health Related Appointments: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 17. Rehabilitation: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 18. Others: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 19. US Non-Emergency Medical Transportation Market Share (%) – by End User, 2023 and 2031

Figure 20. Hospitals and Clinics: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 21. Nursing Homes: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 22. Homecare Settings: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 23. MCO and State Agencies: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 24. Healthcare Payers: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 25. Others: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 26. US Non-Emergency Medical Transportation Market Breakdown by Key Countries, 2023 and 2031 (%)

Figure 27. Northeast: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 28. Midwest: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 29. South: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 30. West: US Non-Emergency Medical Transportation Market – Revenue and Forecast to 2031 (US$ Million)

Figure 31. Growth Strategies in the US Non-Emergency Medical Transportation Market

Your Key Concerns Addressed - Question & Answer
Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.

Is there support available if I can't access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Please use your business email for quicker response
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.